Epinastine ophthalmic - AbbVie
Alternative Names: Alesion LX Ophthalmic Solution; Alesion Ophthalmic Solution; AlesionCream; DE-114; DE-114A; Elestat; Epinastine eye drops; Epinastine hydrochloride; Epinastine hydrochloride high dose; Purivist; Relestat; STN-1011402; STN-1011403Latest Information Update: 24 Jun 2024
At a glance
- Originator Boehringer Ingelheim
- Developer AbbVie; Santen Pharmaceutical
- Class Antiallergics; Dibenzazepines; Eye disorder therapies; Imidazoles; Nonsedating antihistamines; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists; Histamine H2 receptor antagonists; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Allergic conjunctivitis